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EXECUTIVE SUMMARY
 
Drinking alcohol during pregnancy can cause fetal alcohol 
spectrum disorders (FASDs). The term FASDs is used to define 
the spectrum of physical, mental, behavioral, and/or learning 
disabilities that can result from prenatal alcohol exposure. Fetal
alcohol syndrome (FAS) is one of the most severe outcomes of
drinking alcohol during pregnancy. FASDs are preventable if 
women do not drink during pregnancy. 
Since FAS was first identified in 1973, efforts have been 
under way to prevent alcohol-exposed pregnancies (AEPs) and
reduce the risk of FASDs. While significant progress has been 
made, alcohol use continues to be prevalent among women 
of childbearing age. Recent data show that 12% of pregnant 
women aged 18–44 years reported consuming alcohol during
the past month, and about 2% reported binge drinking during
that time. Also, 52.4% of nonpregnant women aged 18–44 
years reported drinking during the past month, and 11.5% 
reported binge drinking. These data suggest that more work 
needs to be done to develop effective, evidence-based FASD 
prevention strategies to address the diverse needs of all women
of childbearing age—those who are pregnant, who are trying to 
become pregnant, and who might become pregnant. 
This report is a collaborative effort of the National Task 
Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect 
(NTFFASFAE), the Centers for Disease Control and 
Prevention’s (CDC) National Center on Birth Defects and 
Developmental Disabilities (NCBDDD) FAS Prevention Team, 
National Center for Health Marketing Community Guide 
Branch, and Research Triangle Institute International (RTI).
Evidence for this report began with a systematic search of the
literature to identify community-level FASD interventions and
policies that can prevent AEPs and reduce the prevalence of
physical, mental, behavioral, and learning disabilities due to 
prenatal alcohol exposure. This evidence, along with the findings 
and recommendations of the U.S. Preventive Services Task 
Force on behavioral counseling interventions for alcohol misuse, 
helped lay the groundwork for the information presented 
in this report. The report reviews the current evidence on 
prevention strategies to reduce alcohol use and AEPs, provides 
recommendations on promoting and improving these strategies, 
and offers future research directions in the field of FASD 
prevention. It also serves as a guide for those in the research and
practice fields interested in selecting and implementing effective, 
scientifically tested interventions for women at risk for an AEP. 
The report highlights the critical importance of alcohol 
screening using validated screening tools in identifying 
women at risk for alcohol misuse and AEPs. The prevention 
strategies described in the report are categorized using 
a prevention framework of universal, selective, and 
indicated prevention. Universal prevention interventions 
attempt to promote the health of the general public or 
a particular group, regardless of risk, while selective and 
indicated prevention strategies are more targeted and 
intensive falling along a continuum of care depending on 
the severity of the problem. 
At this time, research on the effectiveness of universal 
prevention interventions to reduce AEP or FASDs is 
insufficient; however, such interventions might contribute 
to an increase in knowledge and awareness about the 
risks of alcohol use during pregnancy among the general 
population, including women of childbearing age. The 
task force report indicates that universal interventions 
specific to reducing AEPs require improved evaluation 
methodologies to determine their effectiveness. The report 
also recognizes the value of broad-based alcohol policies 
and environmental changes geared towards the general 
public in reducing per capita alcohol consumption and 
excessive alcohol use. Effective population-based alcohol 
policy efforts could ultimately affect alcohol use among 
women of reproductive age and the prevention of FASDs. 
One of the most widely studied prevention strategies 
employs brief alcohol interventions targeting at-risk 
drinking. Studies of brief intervention have been 
successfully conducted in a wide range of settings, 
including primary care, emergency departments, and 
colleges. The report highlights studies of effective, brief 
interventions for alcohol use tested among the general 
population and also describes effective interventions 
targeting pregnant women, preconceptional women, and 
women at greatest risk for having a baby with an FASD. 
Selecting effective, evidence-based interventions is an 
important step towards improved FASD prevention. The 
challenge ahead is how to ensure that effective strategies 
are implemented and integrated into existing systems. 
This requires capacity and commitment at multiple 
levels, including service providers, insurance companies, 
policy makers, and consumers, in order to deliver and 
integrate effective strategies, such as brief interventions, 
into community-based health and social service settings. 
Collaboration and strong partnerships across federal, state, 
and local agencies; academia; medical and social service 
delivery systems; and consumers are also essential in order 
to continue to develop a continuum of evidence-based 
care for women with alcohol use problems. 
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Based on the evidence provided in this report, the 
NTFFASFAE proposes several recommendations (Table 1) 
to support the development, implementation, and expansion 
of evidence-based strategies to prevent AEPs; to stress the 
importance of alcohol screening and provider education; 
and to promote further research on how best to identify and 
intervene with women at greatest risk for alcohol-affected 
pregnancies. The task force also puts forward several topics 
for consideration as future research directions in the FASD 
prevention arena. 




Expand and test methodological approaches for assessing the effects of universal prevention
strategies on alcohol use patterns and reproductive health outcomes of childbearing-aged women. 
Promote the implementation of effective population-based interventions for reducing alcohol-related
harms in the general population, including women of childbearing age, as they are validated. 









Ensure that funded intervention studies on alcohol use, abuse, and dependence include analyses of
gender and age effects and examine pregnancy outcomes where possible. 
Promote the use of evidence-based intervention strategies tested in primary care, emergency 
rooms, and college settings for use in populations of childbearing-aged women at risk for an
alcohol- exposed pregnancy. 
Establish formal alcohol screening, using validated instruments, and brief intervention programs
that are culturally and linguistically appropriate for women of childbearing age. 
Expand the education and training of health and social service professionals in the areas of
screening and intervening with women at risk for alcohol-exposed pregnancies. 
Ensure access to appropriate alcohol treatment services for women of childbearing age, especially
those with treatment barriers, such as pregnant women and adolescents. 
Ensure that alcohol treatment options for all childbearing-aged women take into consideration their
unique needs, such as pregnancy, co-occurring disorders, and other special treatment needs.
Conduct further research aimed at implementing and evaluating treatment and intensive
case-management approaches for women at highest risk of having a child with a fetal alcohol
spectrum disorder. 
Promote research investigating interventions focused on the potential intergenerational effects of








       
 




              
 





        
 












                  
             
 
 






                
 
 
              
INTRODUCTION 
Alcohol misuse is a serious, worldwide public health issue that can result
in a wide range of physical, psychological, and social problems affecting
the individual, the family, and the community. Drinking alcohol during
pregnancy increases a woman’s risk of having a baby with birth defects
and developmental disabilities. Alcohol consumption during pregnancy is 
recognized as the cause of fetal alcohol spectrum disorders (FASDs). FASD
is a term used to define the spectrum of physical, mental, behavioral, and/ 
or learning disabilities that can result from prenatal alcohol exposure [1]. 
Fetal alcohol syndrome (FAS) is one of the most severe outcomes of drinking
alcohol during pregnancy and is characterized by facial malformations,
growth deficits, and neurodevelopmental problems [2]. It should be noted
that throughout this report, the terms FAS and FASDs are both used. FAS is 
used when describing the diagnostic criteria specific to the condition of fetal
alcohol syndrome or when reporting surveillance data on the condition. The 
term FASDs is used when discussing the full range of effects that can occur
from drinking during pregnancy.  Efforts have been underway for several
decades to develop strategies to prevent alcohol-exposed pregnancies (AEPs)
and reduce the risk of FASDs. 
In 2002, the National Task Force on Fetal Alcohol Syndrome and Fetal
Alcohol Effect (NTFFASFAE), a federal advisory committee, released its 
first recommendations [3]. Among these recommendations were several
items focused on prevention, including recommending the reissuance of the 
U.S. Surgeon General’s advisory on drinking during pregnancy [4] and the
development of a report to review the evidence for effective prevention and
treatment strategies for women at risk for or engaging in prenatal alcohol use.
In 2004, after deliberations on and publication of Fetal Alcohol Syndrome: 
Guidelines for Referral and Diagnosis [5], the NTFFASFAE decided to focus 
its attention on FASD prevention. The Task Force Prevention Working
Group (PWG) was established to guide the development of a report
describing evidence-based prevention strategies to reduce AEPs and outline
recommendations to further promote the implementation of such strategies. 
To accomplish this, the staff of the Centers for Disease Control and
Prevention’s (CDC) National Center on Birth Defects and Developmental
Disabilities engaged the Community Guide Branch at CDC’s National Center for Health Marketing and Research
Triangle Institute International (RTI) to assist the PWG in this work. RTI conducted a systematic search of the literature 
to identify community-level FASD interventions and policies that can prevent alcohol-exposed pregnancies and reduce 
the prevalence of physical, mental, behavioral, and learning disabilities due to prenatal alcohol exposure. The review
focused on community-level interventions and policies because other systematic reviews either have been completed or
are currently under way to explore both clinical interventions and population-based strategies addressing alcohol misuse. 
For example, in 2004, the U.S. Preventive Services Task Force engaged in a systematic review that resulted in clinical
recommendations on screening and behavioral counseling interventions in primary care settings to reduce alcohol misuse
[6]. Also, the Task Force on Community Preventive Services, coordinated by CDC, is actively engaged in systematic
reviews to assess the effectiveness of population-based alcohol prevention strategies that affect people in the general
population, including women of childbearing age. 
This report reviews the current evidence on prevention strategies to reduce AEPs, provides recommendations on
promoting and improving these strategies, and offers future research directions in the field of FASD prevention. This 
document also serves as a guide for those in the research and practice fields interested in selecting and implementing
effective, scientifically tested interventions for women at risk for an AEP. In addition, the report also highlights the
importance of continued collaboration across federal, state, and local agencies; academia; medical and social service 
delivery systems; and families to integrate scientific findings into public health prevention strategies. 
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BACKGROUND AND EPIDEMIOLOGICAL OVERVIEW
 
Since it first appeared in the scientific literature in the United
States in 1973 [2], FAS has proved to be a challenging condi­
tion for both the scientific community and the health care 
delivery system. Through the efforts of the U.S. Congress, 
federal agencies, professional organizations, and other nongov­
ernmental organizations, much has been achieved in gaining a 
better understanding of the effects of prenatal alcohol exposure 
on the developing fetus and FAS specifically [7]. After more 
than 30 years of research, there is a consensus in the field that
prenatal alcohol exposure is responsible for not only FAS, 
but also for a spectrum of disorders relative to the amount of 
exposure. This view was introduced in 1996 in the report of 
the Committee to Study Fetal Alcohol Syndrome, convened 
by the Institute of Medicine (IOM) under a congressional 
mandate to the National Institute on Alcohol Abuse and Alco­
holism (NIAAA) [8].
The IOM committee delineated five diagnostic categories: 
(1) FAS with a history of maternal alcohol exposure; (2) 
FAS without a history of maternal alcohol exposure; (3) 
partial FASa  with a history of maternal alcohol exposure; 
(4) alcohol-related birth defects (ARBDs); and (5) alcohol-
related neurodevelopmental disorder (ARND). Diagnostic 
criteria were broadly defined for each of the five categories 
with a recommendation that research be conducted to 
“evaluate the utility, reliability, and validity of this scheme 
for classification and diagnosis” [8]. FAS was described as a 
characteristic pattern of facial anomalies that included short 
palpebral fissures, thin upper lip, flattened philtrum, and 
flat midface; growth retardation; and evidence of central 
nervous system (CNS) abnormality. In 2000, researchers 
from the University of Washington in Seattle published a 
comprehensive approach to diagnosing the full spectrum of 
conditions resulting from prenatal alcohol exposure using 
a 4-digit coding system [9]. That same year, the American 
Academy of Pediatrics recommended use of a similar 
diagnostic approach to pediatricians and urged them to 
increase their awareness of FAS, partial FAS, ARND, and 
ARBD [10]. 
In an attempt to promote consistent use of uniform diagnos­
tic criteria for FAS, CDC and the NTFFASFAE published 
guidelines for referral and diagnosis of FAS in 2004 [5]. These
guidelines focused on FAS because scientific evidence to sup­
port specific clinical criteria for prenatal alcohol-related condi­
tions other than FAS was lacking. These guidelines refined the
broad definitions of the IOM report and further delineated 
aspects of functional central nervous system disorders associat­
ed with FAS. The guidelines also endorsed a uniform definition
aPartial FAS is “assigned to patients with confirmed maternal alcohol exposure to substantial
amounts of alcohol in gestation, some components of the facial features of FAS, and any of
the following: evidence of growth deficiency, CNS [central nervous system] neurodevelop­
mental abnormalities, or a complex pattern of behavioral and cognitive abnormalities.” [8] 
of FASD as “an umbrella term describing the range of effects
that can occur in an individual whose mother drank alcohol 
during pregnancy. These effects may include physical, mental, 
behavioral, and/or learning disabilities with possible lifelong
implications. The term FASD is not intended for use as a clini­
cal diagnosis.” One recent study [11] proposed a diagnostic ap­
proach to assessing the conditions within the spectrum offering
further clarification of the criteria outlined in the 1996 IOM 
report. More research on determining specific diagnostic crite­
ria for prenatal alcohol-related conditions (e.g., ARND) other
than FAS is needed. The NTFFASFAE recently highlighted the 
critical importance of this issue along with improved diagnos­
tic access and capacity for FASDs and continued support for
intervention research and essential services for individuals with
FASDs and their families. Task force recommendations in these 
areas are further detailed in the recent research and policy re­
port, A Call to Action: Advancing Essential Services and Research 
on Fetal Alcohol Spectrum Disorders [12]. 
Efforts to establish reliable estimates of FAS prevalence have 
improved over time as clinical definitions have increased 
in specificity. Population-based surveillance estimates vary 
depending on the methodology used and the populations 
being studied. Estimates from CDC range from 0.2 to 1.5 
cases per 1,000 livebirths [13–16], while estimates drawn 
from studies using a variety of methods (passive surveillance, 
active surveillance, and clinic-based studies) range from 0.5 
to 2 cases per 1,000 livebirths [17]. Estimates of FAS in 
combination with other conditions along the spectrum (partial
FAS, ARNDs, and ARBDs) range from 9 to 10 cases per 
1,000 livebirths [17, 18]. While all of these estimates have 
limitations, it is clear that prenatal alcohol exposure can result
in birth defects of major organ systems, growth disorders, 
and damage to multiple structures in the brain resulting in 
permanent and lifelong disabilities [7]. 
Since 1973, prevention has been a critical component in efforts
to reduce prenatal exposure to alcohol and the prevalence 
of FASDs. The importance of developing effective FASD 
prevention strategies has been acknowledged through increased
congressional support and federal resources devoted to efforts 
to reduce AEPs, to develop strategies to intervene with women
at risk, and to support individuals with FASDs and their 
families. A timeline outlining national efforts to prevent AEPs 
is provided in Appendix A. 
Despite ongoing efforts to inform women about the risks of 
alcohol use during pregnancy, alcohol use continues to be 
prevalent among childbearing-aged women in the United 
States. While most women reduce alcohol consumption after 
learning that they are pregnant [19], approximately 500,000 
pregnant women report alcohol use within the past 30 days 
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ANY USE: BINGE: 
≥ 5 drinks on one occasion in past month 1 or more drinks in past month 0 
2001 2002 2003 2004 2005 
Source: Behavioral Risk Factor Surveillance System 2001-2005, CDC. 
Adapted from: Tsai J, Floyd RL, Bertrand, J. Tracking binge drinking among U.S. childbearing-aged women. Prev Med. 2007;44:298-302 
and approximately 80,000 report binge drinking [20]. In 2005, 
among women aged 18–44 years, 12% of pregnant women 
reported consuming alcohol during the past month, and about
2% reported binge drinking (defined as 5 or more drinks on 
one occasion in the past month) during that time (Figure 1). In
that same year, 52.4% of nonpregnant women aged 18–44 years 
reported drinking during the past month, and 11.5% reported
binge drinking (Figure 2). 
Of further concern is that recent studies find the number of 
binge episodes has increased among people who report any 
binge drinking, including women of childbearing age [21, 22]. 
It is estimated that binge drinking prevalence among child­
bearing aged women, aged 18–44 years, for the years 2001, 
2002, and 2003, was 11.9%, 12.4%, and 13.0%,b respectively 
[22]. This represents an increase of 0.9 million women during
that time period who reported engaging in binge drinking [22]. 
Additionally, younger women are more likely to engage in binge
drinking than are their older counterparts [23], which places 
them at risk for unplanned pregnancies and a host of other 
negative consequences [24, 25]. 
b Confidence intervals for these percentages were:  11.9% (11.4, 12.3), 12.4% (12.0, 12.9),
and 13.0% (12.5, 13.5). 
2001 2002 2003 2004 2005 
Source: Behavioral Risk Factor Surveillance System 2001-2005, CDC. 
BINGE: ANY USE: 
≥ 5 drinks on one occasion in past month 1 or more drinks in past month 
Also, many women do not recognize that they are pregnant 
until well into their first trimester, and thus might continue to
drink during the early critical weeks of fetal development [26,
27]. Recent data indicate that 54.9% of women who might 
become pregnantc  reported using alcohol and 12.4% of these
women reported binge drinking [28]. These statistics and 
the fact that almost half of pregnancies in the United States 
are unplanned [29] emphasize the importance of developing 
effective prevention strategies to address the diverse needs of all
women of childbearing age—those who are pregnant, who are
trying to become pregnant, and who might become pregnant. 
cIn this analysis, women who might become pregnant “were defined as those who were 
not using any type of birth control and provided one of the following reasons: wanted a 
pregnancy (52.4%), did not care whether pregnancy occurred (19.1%), did not think they 
would become pregnant (14.3%), did not want to use birth control (5.7%), feared the side 
effects of birth control (4.2%), thought they were too old to become pregnant (1.8%), could
not pay for birth control (1.3%), or had lapsed in use of a method (1.2%). Excluded from
this defined category were women who were not sexually active, had a same-sex partner, had
no sex partner, had undergone sterilization or hysterectomy, were postpartum breastfeeding, 
were currently pregnant, had other unspecified reasons for not using birth control, or did
not provide any reason.” [28] 
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ALCOHOL SCREENING FOR WOMEN AT RISK
 
It is recommended that primary care providers routinely 
screen their adult patients, especially women of reproductive
age, for risk of excessive alcohol use or alcohol abuse 
disorders. Screening in the clinical setting coupled with brief
interventions or referral for treatment of alcohol abuse disorders
has been found to be an effective prevention strategy for FASDs 
as detailed in the following paragraphs. 
Before intervening with a woman at risk for an AEP, screening
for alcohol misuse utilizing a valid screening tool is critical to 
assessing severity of use and determining which intervention is
most appropriate for that particular woman. Before reviewing
the various prevention strategies, the need for alcohol screening
and the use of appropriate screening tools to identify women at
risk will be discussed. 
In accord with the U.S. Surgeon General’s 2005 Advisory on 
Alcohol Use in Pregnancy [4], both the American Academy of 
Pediatrics (AAP) and the American College of Obstetricians
and Gynecologists (ACOG) recommend abstinence from 
alcohol during pregnancy for women who are pregnant or
may become pregnant [1]. Also, it has been shown that past
drinking habits are highly predictive of subsequent prenatal 
consumption so it is important to have some measure of prior
alcohol use patterns [30–32]. Thus, it is beneficial to identify 
and, if necessary, modify a woman’s alcohol use as early as 
possible in pregnancy or, ideally, before conception.
Physicians often have difficulty identifying problematic alcohol
use, despite its prevalence in medical and other clinical settings 
[33]. In addition, evidence suggests that physicians are less
likely to identify alcohol problems among female patients 
than among male patients [34]. Clinicians working in prenatal 
practices face particular challenges. First, many women will 
reduce their alcohol consumption once their pregnancy is
confirmed, but they might have consumed harmful amounts
before their pregnancy was known.This means that the
standard quantity and frequency questions about current 
alcohol use might not be helpful. Second, women might
underreport their prenatal consumption of alcohol. Reasons
include embarrassment, fear, or beliefs that small amounts are 
inconsequential and not worth reporting [35]. Finally, popular 
screening instruments such as the CAGEd (whose use is taught 
in most medical schools) were developed for other populations 
(e.g., heavy drinking males) and are less accurate in identifying
risk drinking by women [36]. 
Screening instruments that are recommended for women
include the T-ACE, the TWEAK, and the Alcohol Use
Disorders Identification Test-Consumption (AUDIT-C) [32, 
36–40], along with the CRAFFT for adolescent populations.
The name of each instrument, except the AUDIT-C, is an 
acronym for the first letters of key words in the test’s questions.
The T-ACE and the TWEAK were specifically developed for
use with pregnant women. 
The T-ACE consists of four questions that take less than a
minute to ask. The questions are: 
(T) TOLERANCE: How many drinks does it take to make 
you feel high? 
(A) Have people ANNOYED you by criticizing your
drinking? 
(C) Have you ever felt you ought to CUT DOWN on your
drinking? and 
(E) EYE OPENER: Have you ever had a drink first thing in 
the morning to steady your nerves or get rid of a hangover? 
The T-ACE has been widely studied among diverse populations 
and has been proven to be a valuable and efficient tool for 
identifying a range of alcohol use among pregnant women and
their partners, and women with infertility, among others [41– 
43]. The T-ACE is also included in Drinking and Reproductive 
Health, A Fetal Alcohol Spectrum Disorders Prevention Tool Kit, 
released by ACOG in 2006. 
d The questions in the CAGE are: C - Have you ever felt you should cut down on your
drinking? A - Have people annoyed you by criticizing your drinking? G - Have you ever felt
bad or guilty about your drinking? E - Eye Opener: Have you ever had a drink first thing
in the morning to steady your nerves or to get rid of a hangover? The T-ACE is a modified
form of the CAGE developed to screen for alcohol use in pregnant women. 
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5 
Similar to the T-ACE, the TWEAK was designed to identify 
risk drinking by pregnant women [32, 38] and consists of 
four screening questions to elicit: 
(T) TOLERANCE for alcohol;
(W) WORRY or concern by family or friends about 
drinking behavior; 
(E EYE OPENER, the need to have a drink in the
morning; 
(A) “Blackouts” or AMNESIA while drinking; and
(K) the self-perception of the need to CUT DOWN on 
alcohol use. 
A total score of 2 or more on the TWEAK is suggestive 
of harmful drinking patterns among obstetric patients [32]. 
In a study examining the usefulness of the TWEAK for a group 
of low-income pregnant women participating in the Special 
Supplemental Nutrition Program for Women, Infants, and
Children (WIC), the specificity of the TWEAK was high for
all racial and ethnic groups studied using a cut point of 2 or 
more; however, sensitivity, while high for White, non-Hispanic
women, was moderate for Black or African-American and 
Hispanic women [44]. 
A recent large epidemiological study examined the use of the 
AUDIT-C on a sample derived from the 2001–2002 National
Epidemiologic Survey on Alcohol and Related Conditions
(NESARC) conducted by the NIAAA [37]. The NESARC
AUDIT-C includes modifications to the first three questions
of the original AUDIT [45]. The AUDIT-C is based solely on 
AUDIT items reflecting alcohol consumption. 
The AUDIT-C questions are: 
	 •	 During	the	last	12	months,	about	how	often	did	you	 
drink ANY alcoholic beverage? 
	 •	 Counting	all	types	of	alcohol	combined,	how	many	 
drinks did you USUALLY have on days when you 
drank during the last 12 months? 
	 •	 During	the	last	12	months,	about	how	often	did	you	 
drink FIVE OR MORE drinks in a single day? 
The AUDIT-C was developed to meet the challenge of 
brevity and ease of administration provided by other brief 
screening instruments. 
Alcohol use among teenage girls is an important public 
health concern and has been associated with decreased use 
of contraception and increased sexual assault and sexually 
transmitted diseases [46, 47]. The CRAFFT is a brief measure 
designed specifically to identify substance-related problems 
among adolescent populations [48]. 
This tool consists of the following five questions: 
(C) Have you ever ridden in a CAR driven by someone 
(including yourself ) who was high or had been using 
alcohol or drugs? 
(R) Do you ever use alcohol or drugs to RELAX, feel better
about yourself, or fit in? 
(A) Do you ever use alcohol or drugs while you are 
by yourself, ALONE? 
(F) Do you ever FORGET things you did while using 
alcohol or drugs? 
(F) Do your family or FRIENDS ever tell you that you 
should cut down on your drinking or drug use? 
(T) Have you ever gotten into TROUBLE while you 
were using alcohol or drugs? 
The CRAFFT measure is simple to score, inquires about 
alcohol and drug use, and has been found to have good 
psychometric properties among a predominantly female 
sample 14 through 18 years of age [49]. The questions 
and scoring information for the T-ACE, the TWEAK, the 
AUDIT-C, and the CRAFFT are in Appendix B. 
Consistent use of a screening instrument such as the T-ACE, 
the TWEAK, AUDIT-C, or the CRAFFT is likely to 
result in significantly improved identification of pregnant 
women at risk for alcohol consumption. For example, in 
one study, 82.8% of 278 T-ACE positive pregnant women 
consumed alcohol while pregnant. However, physicians 
correctly identified only 10.8% of the 278 women as being 
at risk for drinking while pregnant. This is similar to other 
findings in which, despite widespread use of the usual 
methods of inquiry about alcohol use as documented in 
the medical record, the sensitivity of the medical record was 
significantly less than the T-ACE for all levels of drinking 
[43]. Screening for alcohol use with validated screening tools 
has, therefore, been recommended to provide pregnant and 
preconceptional women with up-to-date, comprehensive, 
and effective medical care [50, 51]. 
       
     
      
        
       
 
       
      
       
         
        
       
      
     
 
          
           
        
       
       
         
      
         
 
        
        
 
          
         
       
 
 
       
 
 
       
      
      
         
       
         
      
 
    
CURRENT EVIDENCE 
In preparation for development of this report, the 
NTFFASFAE Prevention Working Group embraced several 




selective, and indicated) should be considered. 
•	 Interventions	considered	should	target	all	women	of	 
childbearing age who are at risk for an AEP. 
The prevention strategies outlined in this report are based 
on the prevention framework previously adapted by the 
IOM Committee to Study Fetal Alcohol Syndrome in 1996.
The framework provides a spectrum of FASD prevention 
approaches that include universal, selective, and indicated 
prevention. Universal prevention is directed at all members 
of a population or a particular group, regardless of risk, 
and can include efforts such as supporting abstinence from 
alcohol use during pregnancy, raising awareness about FASDs, 
and implementing other broad-based alcohol policy and 
environmental strategies (e.g., reducing alcohol availability 
and increasing alcohol taxes). Selective prevention is directed
at populations who might be at greater risk for a particular 
outcome because they are members of a group found to be at 
greater risk than the general population. For example, these 
interventions would be targeted to women of childbearing 
age who drink alcohol. Indicated prevention targets the 
highest risk individuals (e.g., those who can be identified as 
high-risk drinkers, abusers, and/or dependent on alcohol). 
Women who have had a previous AEP, women who are 
currently pregnant and drinking, or women who drink at high
levels and can become pregnant could benefit from indicated 
prevention approaches. These levels of prevention move along a 
continuum from universal to indicated, becoming more specific
and intensive as the severity of the risk behavior increases. It 
is important to note that some of the intervention strategies, 
specifically selective and indicated, discussed in this report 
might be appropriate for more than one of the categories along
the prevention continuum. 
An important caveat in understanding this framework is that
these various intervention approaches together make up a 
comprehensive approach to preventing FASDs. As stated by the
IOM committee in 1996, “a comprehensive FAS prevention
program should provide multiple and overlapping levels of 
reinforcement, incentives, and controls” to prevent prenatal 
alcohol exposure, which would consist of both population-
based strategies and more targeted individual-level interventions 
[8]. The NTFFASFAE recognizes this as well and is also 
committed to identifying what specific approaches are most 
effective based on the evidence to date. Studies exploring the 
effectiveness of multilevel FASD prevention approaches are 
currently underway and will be discussed further in the Future
Research Directions section of this report. 
The following sections describe interventions that show 
the most promise in prevention of AEPs and also provide 
recommendations, developed and approved by the 
NTFFASFAE, to help guide future actions in the areas 
of research, service delivery, education and training, and 
policy development. 
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Universal Prevention 
Within the field of FASDs, universal prevention has been 
defined as those interventions that educate or raise awareness 
of the general public or women of childbearing age [8] about
the dangers of drinking during pregnancy. Several universal 
interventions have focused on FASD prevention, relying on 
mass media, educational materials, media campaigns, and 
alcohol beverage labeling. 
One published study of a mass media (posters and tear-off 
cards) campaign found an overall increase in knowledge 
and awareness of the risks of alcohol use during pregnancy 
among African-American and Latina adolescents [52]. The 
use of warning posters is another health strategy that educates
communities about health and safety risks associated with 
drinking. They are often posted at points-of-purchase to reach 
most consumers, including moderate, heavy, and potential 
drinkers. Warning posters often supplement ongoing alcohol-
education programs and reinforce the federally required health
notices on alcohol beverage containers. Past research indicates
that warning posters boost knowledge of alcohol risks [53, 54]. 
For example, follow-up surveys in New York City conducted 
one year following the introduction of the warning posters, 
showed an increase (14%) in awareness that birth defects are a
consequence of drinking during pregnancy [54]. 
Kaskutas and Graves [53] evaluated the relationship between
exposure to multiple sources of health messages about the risk 
of drinking during pregnancy and awareness and behavior 
related to this risk. A national sample was interviewed and the
results suggested that the level of knowledge increased with an
increasing number of different message sources (e.g., posters, 
warning labels, and advertisements). Among women of 
childbearing age (aged 18–40 years), significantly more women
who were pregnant during the last year had a discussion 
about alcohol and the risk of birth defects in comparison with
women who were not pregnant. Also, the pregnant women 
who drank were significantly more likely to report limiting 
their drinking for health reasons in comparison with the 
nonpregnant women. 
In 1988, the U.S. Congress passed the Alcoholic Beverage 
Warning Label Act, requiring that a warning label must be 
attached to all containers of alcohol beverages. The warning 
label portion that was applicable to drinking during pregnancy 
stated the following: “Government Warning: (1) According 
to the Surgeon General, women should not drink alcoholic 
beverages during pregnancy because of the risk of birth defects 
[55].” Hankin and colleagues [56, 57] examined exposure to
the warning label and its effect on drinking during pregnancy
among inner-city African-American women attending a 
prenatal clinic. After implementation of the label law, there 
was a significant decrease in drinking among nonrisk drinkers,
but no decrease in alcohol consumption was detected among
heavier drinkers. 
As previously shown, universal prevention efforts to reduce 
AEPs or FASDs have demonstrated increased awareness and 
knowledge about the topic of alcohol use and pregnancy, but 
rarely provide data on changes in alcohol consumption or 
reduced risk of an AEP. Thus, there is insufficient evidence on
the effectiveness of universal approaches that prevent AEPs or
FASDs. More research is needed to further explore the effect of
these kinds of strategies. 
When defined more broadly, universal prevention approaches 
targeting the general public focus on limiting alcohol 
consumption through alcohol policies and environmental 
changes. These broad-based strategies are important in 
changing social and cultural norms, as well as in regulating 
activities and environments that promote excessive alcohol 
use among the general population, including women of 
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childbearing age. Although not directly focused on preventing 
FASDs, they could have an indirect effect on FASDs by 
decreasing alcohol consumption among women of reproductive
age. Following are two important examples of recent initiatives 
exploring the efficacy of population-based efforts to reduce 
alcohol consumption and availability and to increase public 
awareness about alcohol-related harms. 
The Community Guide, as mentioned previously, is led by 
the Task Force on Community Preventive Services and is 
supported by CDC [58]. The Task Force on Community 
Preventive Services makes recommendations on the use of 
population-based public health programs and policies based 
on the scientific evidence on what practices have worked to 
improve health and to identify interventions that have not been
adequately researched to help inform the public health agenda.
Community Guide systematic reviews have been conducted for
several health topics, including tobacco use, physical activity,
vaccine-preventable diseases, diabetes, and cancer. The Task 
Force on Community Preventive Services recently selected 
“excessive alcohol consumption” as a priority topic area for 
systematic review. Although all reviews are not yet completed, 
proposed interventions to be evaluated include: enhanced 
enforcement of laws prohibiting the illegal sale of alcohol to 
minors, limiting alcohol outlet density and zoning restrictions, 
limiting alcohol advertising exposure, and increasing alcohol
taxes. The Community Guide offers a systematic, evidence-based
approach to identifying population-based interventions to reduce 
alcohol-related harms. Recommendations on these interventions
will be available soon. 
The World Health Organization (WHO) has recognized the 
importance of alcohol policy internationally since it began in 
1946. In recent years, several publications have been developed 
that emphasize the public health impact of alcohol across 
the world and have outlined strategies to reduce the harmful 
consequences of alcohol consumption. In 2003, the WHO 
Alcohol and Public Policy Group (APPG) conducted an 
extensive review of the literature that focused on 31 policy-
relevant prevention strategies and interventions. These were 
further classified into seven categories: (1) regulating physical
availability of alcohol, (2) pricing and taxation, (3) altering the
drinking context, (4) education and persuasion, (5) regulating
alcohol promotion, (6) drinking–driving countermeasures, 
and (7) treatment and early intervention. 
The WHO noted the following strategies as best practices: 
minimum legal age purchase regulations, government 
monopoly of retail sales, restricted hours or days of sales, outlet
density restrictions, increase in alcohol taxes, sobriety check
points, lowered blood alcohol content (BAC) limits, drivers 
license suspension, graduated licensing for novice drinkers, 
and brief interventions e  for hazardous drinkers. Less effective
practices were also noted, though less effective was not 
intended to imply that the practices should not be considered, 
only that there was a lack of research to support their 
effectiveness. The less effective strategies included: voluntary 
codes of responsible practice in serving alcohol, alcohol-
free activities, alcohol education in schools, college student 
education, public service messages, warning labels, designated
drivers, and ride services. Future research considerations 
include the support of general, population-based strategies 
due to their cost-effective and synergistic effects, as well as 
support of harm reduction and high-risk group strategies. 
Such strategies include screening and brief interventions, 
server interventions, enforcement of minimum purchase 
age, advertising bans, and advertising content or exposure 
restrictions. While the WHO publication did not focus on 
interventions targeted specifically to women of childbearing 
age, it highlights the importance of an evidence-based 
approach to selecting alcohol prevention strategies [59]. These 
kinds of population-based, alcohol policies, if implemented 
successfully, could ultimately affect alcohol use among women
and the prevention of FASDs. 
Overall, these results indicate that universal prevention 
interventions to reduce AEPs might have limited effects; 
however, better methodological approaches to assess 
the effects of these strategies for women of childbearing 
age are warranted. It is also important to recognize that 
universal prevention approaches play an essential role in 
reducing alcohol-related harms, limiting per capita alcohol 
consumption, and raising awareness about the dangers of 
excessive alcohol use and the risks associated with alcohol use 
during pregnancy. 
8 
e Brief alcohol interventions are time-limited sessions aimed at motivating the 
client to change his or her alcohol-related behaviors using a variety of self-help 
and preventive strategies. 
Universal Prevention
Recommendation 1: 
Expand and test methodological approaches for assessing 
the effects of universal prevention strategies on alcohol 
use patterns and reproductive health outcomes of 
childbearing-aged women. 
Recommendation 2: 
Promote the implementation of effective population-based 
interventions for reducing alcohol-related harms in the 
general population, including women of childbearing age, 
as they are validated. 
 
      
         
           
 
       
       
       
      
 
         
 
        
        
      
       
        
        
      
        
      
       
       
        
     
       
       
        
 
 
      
  
    
      
 
         
 
         
      
 
        
     
        
         
 
       
        
          
         
        
 
       
 
        
 
 
      







     
Selective and
Indicated Prevention 
Selective prevention strategies target individuals who are 
at greater risk for a particular outcome because they are 
members of a subgroup known to be at higher risk than the 
general population. Specifically, in regards to FASDs, selective
prevention strategies are directed to women of childbearing 
age who misuse alcohol. These interventions typically are 
more targeted and intensive compared to universal prevention 
interventions and can include outreach, screening, referral, 
and brief intervention activities with the intent of promoting
the health of the mother and preventing or minimizing harm 
to the fetus. Indicated prevention strategies involve a screening
process to identify individuals who exhibit early signs of 
problems related to alcohol use and assist individuals to 
decrease or discontinue their use of alcohol. 
Both selective and indicated strategies are important in 
FASD prevention and fall along a continuum depending on 
the severity of the problem. The following sections discuss 
effective preventive interventions, using selective and indicated 
strategies, to assist individuals who are risk drinkers, including 
women who are pregnant and women of childbearing age. 
After reviewing the literature, the NTFFASFAE identified 
brief alcohol interventions as the most promising approach 
to reducing alcohol use. Effectiveness of brief interventions 
has been demonstrated in multiple settings and with specific 
population groups. Various federal organizations, medical 
boards, businesses and other groups are also recognizing 
the effectiveness of these strategies in reducing alcohol 
and drug misuse in the United States. Several significant 
recommendations and actions related to alcohol screening and
brief interventions can be found in Appendix C. 
Brief Alcohol Interventions: General Population 
Primary Care Settings.
The Center for Substance Abuse Treatment’s Treatment 
Improvement Protocol (TIP) Series #34, Brief Interventions and 
Brief Therapies for Substance Abuse [60] describes brief alcohol 
interventions as time-limited sessions aimed at motivating 
the client to change his or her alcohol-related behavior using
a variety of methods and different types of health providers. 
Brief intervention studies have been conducted successfully in
a wide range of health care settings, including hospitals and 
primary health care locations [61–68]. Individuals recruited 
from such settings are likely to have some contact with a health
care professional over the course of study participation and, 
therefore, would have potential alcohol-related professional 
assistance available if needed. Nonetheless, many or most of 
these patients would not be identified as having an alcohol 
problem by their health care provider and would not ordinarily
receive any alcohol-specific intervention. The results of the 
many clinical trials have been evaluated and summarized in 
meta-analyses and reviews by Bien et al. [69], Kahan et al. 
[70], Wilk et al. [71], Poikolainen [72], Ballesteros et al.[73]; 
Whitlock et al. [74], and Beich et al. [75]. 
Most of the brief alcohol intervention clinical trials were 
conducted in primary care settings. In 2004, the U.S. Preventive
Services Task Force (USPSTF) [74] conducted a systematic 
review of the evidence for the efficacy of behavioral counseling
interventions in primary care to reduce at-risk or harmful 
alcohol use by adults. There were 12 trials that met their quality
and relevance inclusion criteria (adequate randomization;
maintenance of comparable groups; high follow-up rates; 
equal, reliable, and valid measurements; clear definitions of 
the interventions; consideration of important outcomes; and
intention-to-treat analysis). Results indicated that participants in
the experimental groups reduced their average number of drinks
per week by a 13%–34% greater rate than participants in control
groups. Also, the proportion of participants in the experimental
groups who reported drinking at safe or recommended drinking
levels was 10%–19% greater than controls. 
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From this meta-analysis, the USPSTF concluded that: (1) brief
interventions can reduce alcohol use for at least 12 months 
among younger and older adults; (2) both younger and older 
adults are receptive to this approach; and (3) that results 
remain mixed on longer term use and the reduction of alcohol-
related harm. The USPSTF also reported that evidence on 
the effectiveness of counseling to reduce alcohol consumption
during pregnancy was limited; however, studies among the 
general adult population indicated that behavioral counseling 
interventions were effective among women of childbearing age. 
Across meta-analytic reviews [69–75], some key elements of 
successful brief interventions have emerged. These include the 
use of feedback on drinking behavior; advice to change; goal 
setting for change; more than one contact or some follow-up, 
or both; provider training (varied from 15 minutes to 2.5 
hours); and additional staff or system supports for screening or
assessment. However, implementation of brief interventions in
“real world” settings is slow, pointing out the need to address
time, payment, and logistical barriers to begin to make these 
strategies a part of standard clinical practice. 
Emergency Medical Settings.
The emergency department (ED) has long been considered an
important venue for identifying and intervening with patients 
who have alcohol problems, with a special emphasis on those 
presenting with injuries [76–87] as it provides a “window of 
opportunity” when the individual might be more vulnerable,
open to seeing the connection between current consequences
and his or her drinking or drug abuse, and motivated to 
change [83, 84, 86]. In one of the first studies conducted 
in a Level 1 trauma center, patients who screened positive 
for risk drinking were randomized into an intervention or 
control procedure. The intervention was a single motivational
interview (approximately 30 minutes in length). At follow-up,
the intervention group demonstrated an average reduction 
in drinking of 22 drinks per week compared with a 7–drink 
reduction per week for the control group [88]. 
An additional randomized trial [89] targeted injured 
ED patients who screened positive for at-risk drinking. 
Participants in the tailored message booklet with brief advice 
group significantly decreased their average weekly alcohol 
consumption by 48.5% and those in both of the “brief advice”
groups (tailored or generic) significantly decreased their average 
consumption in comparison with the “no brief advice” group.
Additionally, younger adult females (aged 19–22 years) who 
received brief advice were the most likely to decrease their 
heavy episodic drinking. Also, a systematic review on screening 
and brief interventions (SBI) for alcohol problems in EDs [90]
was recently conducted as a supplement to a review previously 
conducted by the USPSTF. Four of the included studies 
[91–94] were conducted in EDs and all demonstrated positive
outcomes. In general, the studies found a significantly lower 
incidence of alcohol-related injuries, drinking and driving, and
alcohol-related problems [93]. It was also noted that following
a brief intervention, over 50% of the patients subsequently 
reported a reduction in alcohol use [91, 94]. Additionally, two
of the included studies demonstrated that brief interventions 
in the ED were effective at increasing referrals of patients 
to substance abuse treatment centers [91, 92]. To this end, 
the study of ED interventions focused on alcohol issues has 
proven to be effective and constitutes fertile ground for future
research, including studies of reproductive-aged women and 
the prevention of AEPs. 
College Settings.
Drinking among college students has long been recognized 
as a significant problem with far reaching public health 
implications [95, 96]. Female college students are especially at 
risk for alcohol-related negative consequences, including sexual
assault and unplanned pregnancies [24, 25]. Despite these 
negative consequences, college women have steadily increased
their levels of alcohol consumption [97]. These trends exist in
disquieting contrast to the increased college and community 
prevention efforts during the same time period, suggesting a 
continued need for more effective intervention approaches. 
Fortunately, brief intervention approaches have been shown 
to be low-cost, effective treatment alternatives for alcohol 
problems among college populations. Effective college drinking
prevention programs frequently employ multicomponent 
approaches to brief intervention strategies, combining 
10 





       
       
      
       
         
       
 
         
      
       
 
        
       




       
 
     
 
        
        
       
        
       
      
 
             
 
 
          
 
         
 
 
       






      
        
 
        
 
        
       
       
 
        
      
           
       
 
        
      
       
       
      
         
     
          
cognitive–behavioralf skills training with norms clarificationg 
and motivational enhancementh [96]. These strategies are similar
to those that youth report that they use themselves to reduce
or stop their own drinking [98]. Collectively, individual- and
group-focused brief interventions have proven valuable in both
preventing and treating alcohol problems among male and 
female college students [99–106]. For example, the Alcohol 
Skills Training Program (ASTP) is a cognitive–behavioral 
alcohol prevention program designed to teach basic principles 
of moderate drinking and ways to cope with high-risk situations 
for excessive alcohol consumption [106]. The ASTP has 
been shown to reduce drinking rates and associated problems
at both 1- and 2-year follow-ups [102]. The Brief Alcohol 
Screening and Intervention for College Students (BASICS) 
[107] consists of an individualized alcohol assessment and 
feedback intervention during two 50-minute sessions. Several
studies have shown the efficacy and effectiveness of BASICS 
with high-risk college students, with results indicating that 
clients who received the BASICS program showed significantly 
greater reductions in negative alcohol-related consequences and
lower reported drinking quantities compared with a high-risk
control sample over a 4-year follow-up period [108]. A recent
study, designed specifically for women, examined alcohol use 
among freshman college students using a single session, brief
motivational intervention that focused on female-specific 
reasons for drinking [105]. Results revealed that, compared with
an assessment-only control group, the group that received the 
brief intervention drank fewer drinks per week, drank fewer 
drinks at peak consumption events, and had fewer alcohol-
related consequences over a 10-week follow-up period. Further, 
the intervention that targeted women’s reasons for drinking was 
more effective in reducing consumption for participants with 
high social and enhancement motivations for drinking. 
f Cognitive-behavioral skills training works to change a person’s problematic beliefs
about a behavior using specific tools and techniques to help modify the behavior (e.g., 
documenting the frequency of the behavior, learning how to manage stress, developing
strategies to avoid situations that trigger the behavior [96].)
g Norms clarification examines a person’s perceptions about the acceptability of a 
particular behavior and uses data to challenge beliefs about the tolerance for the behavior
as well as beliefs about the number of people who engage in the behavior [96]. 
h Motivational enhancement interventions are designed to stimulate a person’s intrinsic 
desire or motivation to change their behavior; these are similar to motivational
interviewing interventions [96]. 
Results from these studies suggest that brief multicomponent
interventions aimed at college students, and those specifically 
designed for women, are effective and should be considered 
when treating college-aged women in multiple care settings. 
Selective and Indicated Prevention:
 
Brief Alcohol Interventions – General Population
 
Recommendation 3:
Ensure that funded intervention studies on alcohol use, abuse,
and dependence include analyses of gender and age effects, and
examine pregnancy outcomes where possible. 
Recommendation 4:
Promote the use of evidence-based intervention strategies 
tested in primary care, emergency rooms, and college settings 
for use in populations of childbearing-aged women at risk for
an alcohol-exposed pregnancy. 
Brief Alcohol Interventions: Pregnant Women 
Pregnant women, who are generally motivated to change their 
behaviors and only infrequently have severe alcohol problems,
might be especially receptive to a brief intervention [109]. 
Many studies and demonstration projects have shown that 
health providers can intervene with pregnant women who 
consume alcohol. In 2001, a review of 22 alcohol intervention
studies in prenatal clinics was conducted [110]. Thirteen of 
these studies were single-treatment interventions of varying 
types. Many of them were able to show that women could be 
screened and recruited successfully in prenatal care settings 
and that women were also able to reduce their drinking during
pregnancy. Nine of the remaining studies did use comparison 
groups when conducting interventions. Overall, the authors 
concluded that brief interventions in controlled trials can 
produce positive results (reduced alcohol use). The authors 
also recommended that brief interventions and motivational 
interviewing are two approaches that can be used by health 
professionals when intervening with pregnant women. 
However, it was also noted that many of the studies reviewed 
11 
          
 
 
       
          
 
         
         
 
      
        
         
         
         
 
 
       
      
        
      
       
        
 
       
      
       
        
       
         
 
         
        
 
        
         
 
       
 
       
        
       
       
         
            
        
     
 
       
         
        
          
       




        
        
      
            
         
 
         
           
       
       
 
        
          
      
were limited by lack of control groups, small numbers of heavy 
drinkers, and an inability to evaluate the effects of treatment,
suggesting that more research in this area is needed. 
Two more recent randomized trials of brief interventions for
alcohol use by pregnant women highlight current research 
advances in this area. The first study by Chang and colleagues 
[111] was a randomized trial to test the effectiveness of a brief
intervention in the reduction of prenatal alcohol use by 304 
women when a partner was included. The women had positive 
T-ACE results and were considered at risk for drinking while
pregnant. All completed initial diagnostic and postpartum 
interviews. Less than 20% of the participants were abstinent 
from alcohol at enrollment, which occurred at a median of 
11.5 weeks of gestation. Those who drank averaged more than 
1.5 drinks per episode. With a 95% follow-up rate, prenatal 
alcohol use declined in both the treatment (brief intervention)
and control groups. Factors associated with increased prenatal
alcohol use after randomization included more years of 
education, extent of previous alcohol consumption, and 
temptation to drink in social situations. Brief interventions for 
prenatal alcohol use reduced subsequent consumption most 
significantly for the women with the highest consumption 
initially. Moreover, the effects of the brief intervention were 
significantly enhanced when a partner participated. 
Another study by O’Connor and Whaley [112] involved 255
pregnant women who reported drinking alcohol and were 
participants in the Special Supplemental Nutrition Program 
for Women, Infants and Children (WIC) program. These 
women were randomized by WIC center to an assessment 
only or brief intervention group. The brief intervention 
consisted of 10- to 15-minute sessions of counseling by a 
nutritionist. Participants were followed to the third trimester
of pregnancy. The majority (87%) of the women required only 
one brief intervention to attain abstinence from alcohol use. 
Women in the brief intervention were five times more likely to
report abstinence from alcohol use after intervention than the 
women in the assessment only group, although women in the 
assessment only group also reduced their prenatal alcohol use
significantly. Women who were heavier drinkers (drinking two 
or more drinks maximum per drinking occasion) and received
brief interventions had better newborn outcomes of higher 
birthweights and lengths, and lower mortality rates. 
Brief Alcohol Interventions: Preconceptional Women 
In the late nineties, the CDC sponsored a multisite, single-
arm study (Project CHOICES) to test the feasibility and 
effect of a motivational intervention to reduce alcohol 
consumption or increase the use of effective contraception, 
or both, among nonpregnant women who were at risk for 
an AEP. This was the first study to target a group at risk 
because of both contraceptive and alcohol use patterns. The 
intervention included four brief, motivational interviewing 
(MI) counseling sessions with a mental health professional and
one contraceptive counseling session with a family planning 
clinician. Of the 230 eligible women, 190 were enrolled in 
the study, and 143 (75.3%) completed a 6-month follow-
up interview. At 6-month follow-up, 68.6% were no longer 
at risk for an AEP. Of those, 12.6% reduced drinking only; 
23.1% used effective contraception only; and 32.9% reduced 
drinking and used effective contraception. The results were 
consistent across the diverse sites. The promising results from
this innovative, dual-focused (alcohol use and contraception)
approach used in Project CHOICES provided the basis for the
development of a randomized clinical trial (RCT) to further 
test these methods [113]. In the Project CHOICES RCT, 
Floyd and colleagues [114] randomized 830 nonpregnant 
women in an MI trial and followed 593 of them for 9 months. 
At follow-up, the intervention group was found to have a 
significant decrease in the risk for AEPs, including a significant
decrease in risky drinking (eight or more drinks per week 
or five or more standard drinks in a day), and a significant 
increase in effective contraceptive use. 
An additional study based on Project CHOICES targeted 
nonpregnant college women of a mid-Atlantic university who 
were at risk for an AEP. Compared to the control group, the
intervention group was found to have a significant decrease 
in the risk for AEPs and a significant increase in using 
contraception effectively at the 1-month follow-up [115]. 
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Various methods have been used to increase knowledge about
alcohol use and pregnancy, including news reports, articles 
in the popular press, public service announcements, and 
billboards. Few studies have assessed the effectiveness of these
efforts on the knowledge of FASDs, attitudes about drinking
during pregnancy, and women’s actual alcohol consumption
during pregnancy. One study [116] examined the use of, 
knowledge about, and attitudes toward alcohol among 
women requesting emergency contraception or a pregnancy 
test, or both. This study also evaluated the effects of a brief 
intervention in educating participants about the risks of FASDs 
via an educational pamphlet with a follow-up immediately 
after reading the pamphlet. The study demonstrated statistically 
significant improvement in mean knowledge scores. 
Selective and Indicated Prevention: 
Brief Interventions – Pregnant and
Preconceptional Women 
Recommendation 5: 
Establish formal alcohol screening, using validated instruments,
and brief intervention programs that are culturally and 
linguistically appropriate for women of childbearing age. 
Recommendation 6: 
Expand the education and training of health and social service
professionals in the areas of screening and intervening with 
women at risk for alcohol-exposed pregnancies. 
Interventions for Women at Highest Risk 
Effective approaches to FASD prevention among the highest 
risk women (i.e., mothers who have previously given birth to
an alcohol-affected child) could have a significant effect on the
problem. However, reaching women at highest risk is difficult
and their treatment is complex. In reviewing the prevention 
literature addressing alcohol misuse, there were many 
substantive studies that did not include gender-specific findings 
because of the small number of female participants. Given 
the many differences between males and females in alcohol 
dependence and its effects, more gender-specific research and 
analyses of available data are clearly needed. 
Studies confirm the heightened vulnerability of women to 
alcohol dependence in that women advance more quickly 
from regular use to dependence and treatment than do men
[117]. Ensuring that childbearing-aged women who are
alcohol dependent are deftly identified and treated requires a
continuum of health care services that includes initial screening,
in-depth assessment, specialized treatment, and relapse 
prevention [118]. Brief interventions alone are not considered
adequate treatment for this population [119]. Further, ensuring
long-term abstinence after treatment requires intensive case 
management and aftercare [120]. Evidence-based treatment
options for alcohol-dependent childbearing-aged women 
include both behavioral and pharmacological interventions. For
those who are pregnant while still using alcohol, treatment is 
complex [121, 122], and even further specialized when those 
who are pregnant are still adolescents [123].
Women with Alcohol Dependence. 
Substance abuse treatment programs specifically designed for
women can be beneficial in improving treatment outcomes. 
Improvements can include changes in substance use, mental 
health symptoms, perinatal or birth outcomes, employment, 
self-reported health status, and HIV risk reduction [124]. 
Strategies in the treatment of alcohol dependence disorders 
include treatment matching (level and intensity) and modality 
matching (specific therapies) [125, 126]. In a landmark, 
large-scale study (Project MATCH) [127], three prevailing 
behavioral therapies used in the treatment of alcohol dependent
adults — Cognitive Behavioral Therapy (CBT), Twelve-Step
Facilitation (TSF), and Motivational Enhancement Therapy 
(MET) — were matched with a variety of client attributes to
test the benefits of treatment matching. The study consisted 
of two parallel randomized controlled studies, one conducted
among alcohol dependent participants receiving outpatient 
therapy and the other conducted among participants receiving
aftercare therapy following inpatient or day treatment in a 
13 
         
        
         
         
       
         
         
          
           
 
      
        
       
      
         
      
 
 
         
         
          
 
       
       
       
         
       
 
 
          
        
      




       
         
 
      
     
     
     
        
     
       
        
       
       
       
 
    
       
 
 
        
      
         
 
 





      
 
   
hospital. The overall aim of each study was to determine 
the responses of subgroups of participants to CBT, TSF, 
and MET as measured by the percentage of days abstinent 
(PDA) and the average number of drinks per drinking day 
(DDD). Study participants were randomized into the three 
treatment therapies over a 12-week period and assessed at five 
follow-up periods: 3, 6, 9, 12, and 15 months. Participants 
in the CBT and TSF conditions were seen weekly and those 
in the MET condition were seen for four sessions at the first, 
second, sixth, and twelfth weeks. Project MATCH participants
showed significant and sustained improvements in increased 
PDA and decreased number of DDD. Results also found 
no clinically significant outcome differences in the three 
treatment conditions overall and significant matching results 
only for psychiatric severity and TSF (in support of assigning 
outpatient clients without psychopathology to TSF). Overall, 
the study findings supported the utility of all three treatment
therapies with the potential for cost-savings for the four-session
MET, which was lower in intensity but equally as effective 
as the others. The only gender-related effect reported in the 
study was that gender was predictive of the PDA for those 
participants receiving aftercare therapy. Males reported fewer
abstinent days than females over the follow-up period. 
Some studies have found that self-help organizations such 
as Alcoholics Anonymous (AA) are cost-effective adjuncts to 
treatment [128, 129] in that they provide daily and weekly 
opportunities for support [129]. In the original Project 
MATCH Study, AA attendance was encouraged for participants
in the TSF and MET intervention groups. In a follow-up study
of Project MATCH at 3 years, 49% of participants from all 
three treatment groups reported attending AA in the 90-day 
period before the follow-up interview [130]. Gender-related 
effects were not reported. A recent Cochrane review [128], 
however, found no conclusive evidence on the effectiveness of
AA or TSF interventions in reducing alcohol use and achieving
abstinence, although the authors also acknowledged that there
were some limitations in the studies reviewed. Additional 
studies on the effectiveness of AA and other 12-step programs 
are needed. 
Studies have investigated the efficacy of pharmacological 
interventions (naltrexone and acamprosate) for alcohol 
dependence treatment in specialized and nonspecialized 
settings, with and without behavioral interventions. 
While reviews of earlier studies found both naltrexone and 
acamprosate efficacious in treating alcohol dependence 
[131, 132], a more recent randomized controlled trial 
funded by NIAAA found efficacy for naltrexone with or 
without behavioral interventions, but did not find efficacy 
for acamprosate alone or in combination with behavioral 
interventions [133]. Samples used in these studies included 
both men and women; however sample sizes for women tended
to be smaller than for men. 
Guidelines for prescribing medications (naltrexone, 
acamprosate, and disulfiram) have been published by NIAAA 
in their recent clinical guide, Helping Patients Who Drink Too
Much [134]. The guide also indicates that pharmacotherapy for
alcohol dependence is most effective when combined with some 
behavioral support but not necessarily specialized, intensive 
alcohol counseling. Also, it is important to know that none 
of these medications have been approved by the U.S. Federal
Drug Administration for use during pregnancy, but they might
prove to be useful in reducing alcohol dependence among 
general populations, including nonpregnant, childbearing-aged
women in specialized and nonspecialized primary care settings.
Substance abuse treatment protocols are also available from the
Substance Abuse and Mental Health Services Administration
(SAMHSA) [118, 135] for various audiences, including 
pregnant women, that can be beneficial to clinicians in primary
and specialized care settings. 
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Tailored Substance Abuse Treatment Interventions.
There is a growing literature describing the availability and 
efficacy of substance abuse treatment for women, including 
those who are pregnant [122, 136–137]. Tailoring substance
abuse treatment to women often leads to better outcomes 
[138]. Availability of prenatal care and onsite therapeutic 
childcare and access to comprehensive programming are some 
of the factors found to enhance treatment completion, length 
of stay, and positive child and mother outcomes, and to reduce
mental health problems [122]. 
Other studies have evaluated supportive educational 
interventions among very high-risk substance-abusing women. 
One study [139] focused on pregnant and postpartum 
substance-abusing mothers and their families, while another 
study [140] focused on young women with FASDs. 
In both studies, women were enrolled in an intensive, 
one-on-one intervention. The primary focus of the 
intervention was to assist the participants in obtaining drug 
and alcohol treatment, staying in recovery, considering 
family planning, and addressing the complex issues that 
arise as a result of dysfunctional lives (i.e., lack of housing, 
domestic violence, and child custody and other legal issues) 
through relationship-oriented, intensive one-on-one support
and education. The results were positive for treatment 
participation, abstinence from alcohol use, and use of reliable
birth control. There was also a decrease in subsequent 
pregnancies in the target populations. 
For the prevention of FASDs, one strategy growing 
increasingly possible is to identify and seek out women 
who are at known risk for producing children with FASDs 
because they have already borne an alcohol-affected child 
[141, 142]. U.S. data indicate that these are women with high 
rates of both unintended and alcohol-exposed pregnancies 
[143]. Data from South Africa indicate that these might be 
women who have poor nutrition and possibly have FASDs 
themselves [142]. Overall, the level of risk for producing 
a child with an FASD is influenced by environmental and 
behavioral conditions that vary between populations and 
among individual women, and by family genetic histories. 
One feasible method for finding and serving women at known 
risk for bearing a child with an FASD is through specialized 
FASD diagnostic clinics [144, 145]. Another method is 
through community mobilization for outreach, identification,
and service provision to women at known risk for an AEP, 
as part of a multilevel, comprehensive FASD prevention 
program [146]. Descriptive data about these high-risk women
emphasize the importance of providing social support and 
mental health treatment as well [144]. 
In sum, there are many types of interventions that can be 
implemented for women of childbearing age who require 
support to abstain from alcohol use before, during, and after 
pregnancy. Studies indicate that active, tailored interventions
can decrease alcohol use and subsequent AEPs among these 
high-risk women, with benefits to their offspring as well. 
Intergenerational Strategies for Prevention 
and Intervention. 
Education is an important area of intervention for families and
children of alcoholics, because alcohol dependence and FASDs
can be intergenerational phenomena. An estimated 13%–25%
of children of alcoholics are likely to become alcoholics 
themselves [147]. These findings underscore the need for 
preventive efforts aimed at addressing familial predispositions 
for alcohol abuse among children of alcoholics, especially 
with women of child-bearing age. Information about parental
alcoholism can also be useful in assessing risk for an AEP. A 
recent review on prevention and intervention strategies for 
working with children of alcoholics [148] highlighted several
basic prevention elements that should be included across 
existing intervention programs for children of alcoholics. These 
include: (1) providing accurate information and education 
about alcohol, (2) promoting specific social skills and coping
strategies, (3) providing social support and addressing 
socioemotional issues, and (4) identifying alternative activities 
to substance use. For individuals with FASDs who are raising 
children, tailored and intensive education and support for 
these caregivers are especially important to prevent alcohol 
dependence among their children. 
Interventions for Women at Highest Risk 
Recommendation 7: 
Ensure access to appropriate alcohol treatment services for 
women of childbearing age, especially those with treatment 
barriers, such as pregnant women and adolescents. 
Recommendation 8: 
Ensure that alcohol treatment options for all childbearing-
aged women take into consideration their unique needs, 
such as pregnancy, co-occurring disorders, and other special 
treatment needs. 
Recommendation 9: 
Conduct further research aimed at implementing and 
evaluating treatment and intensive case-management 
approaches for women at highest risk of having a child with a 
fetal alcohol spectrum disorder. 
Recommendation 10: 
Promote research investigating interventions focused on 
the potential intergenerational effects of prenatal alcohol 






        
         
       
 
        
       
           
        
       
 
     
 
         
      
        
        
      
        
     
       
      
       
        
     
       
       
        
          
      
 
      
        
        
      
        
         
       
 
          
       
          
 
 
         
 
 
      
       
 
      
        
       
        
        
        
       
      
       
        
 
       
 
       
      
 
 
       
 
         
      
       
       
          
      
        
     
       
      
        
         
       
      
    
       
     
         
FUTURE RESEARCH 
DIRECTIONS 
The following paragraphs outline a number of areas for further
exploration and research to improve efforts to reduce AEPs. 
Improved Surveillance and Monitoring:
Over the past 30 years, considerable progress has been made in
the area of FASD prevention. Unfortunately, one major barrier 
to evaluating prevention programs has been the lack of baseline 
prevalence data on FAS and other alcohol-related conditions. 
Standardized, long-term FASD surveillance methods to track
the spectrum of conditions and the continued monitoring of 
risk factors and behaviors of childbearing-aged women need 
to be in place in order to better measure the prevalence of 
FASDs, understand the populations at greatest risk, and assess 
if evidence-based interventions are having an effect. Also, 
finding ways to identify women at highest risk because of prior
alcohol-affected pregnancies is another surveillance measure 
that could inform FASD prevention efforts. 
How Brief Interventions Work:
It is clear that brief alcohol interventions should be widely 
disseminated, supported, and integrated into medical, social 
service, and other venues. Brief interventions can be done 
in a variety of ways using cognitive behavioral approaches 
or motivational interviewing techniques; can be delivered 
in different settings; and have been tested with diverse 
populations, including pregnant and nonpregnant women. 
However, more research is needed to better understand 
how brief interventions work. Deconstructing these types 
of interventions to discover which components are essential 
for success can help inform implementation of these types 
of interventions. Specific components needing further 
exploration include: the optimal number of sessions required 
in an intervention; the training and qualifications needed 
to deliver the interventions, the most effective modes of 
delivery (e.g., face to face, self help, and online), and effective 
adaptation of brief interventions to different cultures. 
Women’s Contraceptive Practices:
Several brief interventions and longer term intensive 
interventions for women at highest risk have been successful 
in using a dual approach focused on reducing alcohol 
consumption or improving effective contraception, or both. 
Many pregnancies in the United States are unplanned [29], 
so continued efforts to better understand the role of family 
planning in preventing FASDs is critical, especially when 
working with preconceptional women. 
Use of the Internet and Other Technologies:
Consumer use of e-health tools, such as the Internet and other 
kinds of electronic technologies, continues to grow. These 
methods are appealing not only because of lower cost, ease of 
use, and interactivity, but also because they provide a degree of
anonymity when dealing with a potentially sensitive topic such
as alcohol misuse. A 2006 Internet survey conducted by the 
Pew Internet and American Life Project revealed that 8 out of
10 American adults had looked online for health information,
making this an important vehicle for communicating 
important health messages [149]. In addition, the U.S. 
Department of Health and Human Services recently published
the report, Expanding the Reach and Impact of Consumer 
e-Health Tools [150]. This report provided a review of recent 
research pertaining to e-health tools used with various 
health topics. The report indicated that, while the research 
is promising, the body of knowledge about which groups 
will engage in and benefit from e-health methods remains 
unclear. Studies evaluating the feasibility and effectiveness of 
Web-based alcohol interventions have also been conducted 
[151–153]. Federal agencies are posting regular blogs and 
podcasts about health topics on their websites, while other 
health and advocacy groups have begun to explore the use of
YouTubeTM, Facebook©, and text messaging as ways to reach 
certain target audiences. More research on the effectiveness of
new technologies to communicate health information or to 
deliver personalized interventions to women of childbearing 
age is needed if we are to take advantage of these technologies
as innovative tools to help reduce AEPs. 
Multilevel FASD Prevention Approaches:
While current evidence points to screening and brief 
intervention as a promising approach to prevention of AEPs,
it is important to recognize that efforts are also underway 
to assess the effectiveness of multilevel, communitywide 
approaches to preventing FASDs. Two studies, funded by 
the NIAAA, are testing the FASD prevention framework 
put forward by the IOM in 1996. The first study targets 
participants from four Northern Plains Indian communities, 
two control groups, and one urban research site. Using 
research and prevention techniques developed previously, 
this project is assessing the effectiveness of comprehensive, 
communitywide FASD prevention at the universal, selective, 
and indicated levels, and is identifying those specific strategies 
that are most successful. Some of the strategies being tested 
include: targeted messages to specific groups, routine screening 
for alcohol use, brief alcohol interventions, motivational 
enhancement therapy, community motivation, case 
management, and policy advocacy. The project also monitors 
various epidemiological characteristics of the communities 
such as maternal risk factors for FASDs and the diagnosis 
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of FAS and related conditions, and uses a combination of 
control and pre- and post-measure designs to assess the specific
prevention techniques. 
The second study is a multisite efficacy trial of a 
comprehensive, communitywide FASD prevention program 
(with urban and rural components) in the Western Cape 
Province of South Africa. The prevention site is matched 
with four comparison communities. This study is similar to 
the previous one in that it will also evaluate the effectiveness
of specific indicated, selective, and universal prevention 
techniques. This trial is unique in that it has been modified 
to address the comorbid condition of HIV/AIDS that many 
South African women face in addition to dealing with an 
alcohol problem or having a child with an FASD, or both. It
also is unique in that the prevention strategies are delivered 
by indigenous workers. This project uses methods similar to 
those of the previous study to monitor maternal risk factors 
and diagnosis of FAS and also assesses specific prevention 
techniques using comparison communities and pre- and post-
prevention designs.
More research is needed on multilevel approaches to FASD 
prevention. These two studies will yield important findings on
the feasibility and effectiveness of multilevel FASD prevention 
approaches and could potentially provide more direction on 
how these interventions should be developed, implemented, 
and evaluated. Also, related to this is the question of how to 
measure the effect of multiple prevention efforts. Recently, 
researchers at the University of Washington assessed the effect
of multilevel prevention efforts in the state of Washington 
over the past 30 years [154]. While more work needs to be 
done in determining the best methods of evaluating multilevel
approaches, the Washington study is a good example of 
how existing data can be used to describe progress made in a
community over an extended period of time. 
Universal Approaches to Prevention:
As indicated previously, universal prevention strategies to 
prevent AEPs can play an important role in FASD prevention
efforts in terms of education and public awareness about the 
risks of drinking during pregnancy; however, carefully crafted 
evaluation studies are needed. Also, broad-based universal 
strategies to reduce alcohol misuse and abuse should not be 
overlooked because they do not directly prevent FASDs. Many
of these kinds of interventions have been effective in regulating
alcohol-related activities and reducing alcohol consumption 
rates, and have the potential to change societal norms about 
alcohol use among the general population. 
CONCLUSIONS 
This report offers a review of effective strategies to reduce 
alcohol misuse and AEPs by using universal, selective, 
and indicated prevention approaches and outlines 
recommendations to guide the successful implementation 
of such strategies. Carefully controlled evaluation studies of 
FASD prevention strategies must continue to be a priority 
in FASD research. These are important in tracking those 
prevention strategies that are working and in assessing possible
new approaches to reducing AEPs. Also, very few prevention
studies measure pregnancy outcomes such birthweight, head 
circumference, presence of facial features, or neurocognitive 
functioning — features related to FASDs. Future prevention 
studies should include pregnancy outcome measures where 
appropriate and possible. This would contribute greatly to 
better understanding the effect of these efforts on preventing 
FASDs, rather than relying solely on proxy measures of 
FASD prevention such as reductions in women’s alcohol 
consumption rates. 
Another challenge ahead is how to ensure that effective strategies 
are implemented and integrated into existing systems. This
not only requires support and commitment at multiple system
levels, including service providers, insurance companies, policy 
makers, and consumers, but also involves the development 
of local capacity needed to deliver and integrate effective 
strategies, such as brief interventions, into community-based
health and social service settings. Finally, collaboration and 
strong partnerships across federal, state, and local agencies; 
academia; and medical and social service delivery systems, and
with consumers are essential to continue the development of a 
continuum of evidence-based care for women with alcohol use 
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1973 Fetal alcohol syndrome (FAS) first identified in the United States by Kenneth L. Jones, David W. Smith, Christy N.
 
Ulleland and Ann P. Streissguth. 
1977	 National Institute on Alcohol Abuse and Alcoholism (NIAAA) organized first research conference on FAS. 
1977	 First federal advisory on alcohol use during pregnancy (initially not an abstinence message) published in the U.S. 
Federal Drug Administration (FDA) Drug Bulletin and Centers for Disease Control’s Morbidity and Mortality 
Weekly Report. 
1978	 NIAAA conducted its first public service campaign with print materials, posters, and television spots. 
1978	 NIAAA-funded prevention program established in Seattle, Washington; other prevention programs followed. 
1981	 First U.S. Surgeon General’s advisory on alcohol use during pregnancy indicating that there is no known safe amount
of alcohol to drink during pregnancy. 
1983	 First municipal ordinance requiring posting of alcohol and pregnancy warning signage in certain establishments 
issued in New York City. 
1989	 Mandatory labeling of birth defects message on alcohol beverages was implemented. 
1990	 National Organization on FAS was established, with state affiliates created over time. 
1991	 CDC’s Fetal Alcohol Syndrome Program began. 
1997	 American College of Obstetricians and Gynecologists and American Academy of Pediatrics joint statement on
alcohol use and pregnancy published in Guidelines for Perinatal Care, 4th edition. 
1996	 Institute of Medicine Report on Fetal Alcohol Syndrome Diagnosis, Epidemiology, Prevention and Treatment
published. 
1996	 Interagency Coordinating Committee on FAS, coordinated by NIAAA, was created. 
1998	 The National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect was mandated by U.S. Congress. 
2002	 The Fetal Alcohol Spectrum Disorders (FASDs) Center for Excellence within the Substance Abuse and Mental
Health Services Administration (SAMHSA) was mandated by Congress. 
2003	 SAMHSA’s FASD Center for Excellence convened the first-ever “Building FASD State Systems” meeting with
additional meetings to follow. 
2004	 Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis released by CDC and the National Task Force on Fetal
Alcohol Syndrome and Fetal Alcohol Effect and endorsed by the March of Dimes, the National Organization on
Fetal Alcohol Syndrome, the Center for Science in the Public Interest, AAP, and ACOG. 
2005	 Release of the updated U.S. Surgeon General’s Advisory on Alcohol Use in Pregnancy. 
2007	 ACOG, in collaboration with CDC, releases Drinking and Reproductive Health, A Fetal Alcohol Spectrum Disorders
Prevention Tool Kit. 
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APPENDIX B: Alcohol Screening Tools 
T-ACE 
T – Tolerance 	 How many drinks does it take to make 
you feel high? 
A – Annoyed	 Have people Annoyed you by 
criticizing your drinking? 
C – Cut Down	 Have you ever felt you ought to Cut 
down on your drinking? 
E – Eye-opener Have you ever had a drink first thing in 
the morning to steady your nerves or 
get rid of a hangover? 
Scoring: The T-ACE is considered to be positive with a
score of two or more. “Yes” answers to the A, C, 
and E questions are each given one point. A reply 
of more than two drinks to the T question is
scored two points. 
TWEAK 
T – Tolerance	 How many drinks can you hold (or how 
many drinks does it take before you begin to 
feel the first effects of alcohol)? 
W – Worried	 Have close friends or relatives worried or 
complained about your drinking in the past 
year? 
E – Eye opener Do you sometimes take a drink in the 
morning when you first get up? 
A – Amnesia	 Has a friend or family member ever told 
you things you said or did while you were 
drinking that you could not remember? 
K - Cut down:	 Do you sometimes feel the need to cut down 
on your drinking? 
Scoring: A woman receives two points on the tolerance 
question if she reports that she can hold more than 
five drinks without falling asleep or passing out. A 
“Yes” to the worry question scores two points, and 
responding “Yes” to the last three questions scores 
one point each. A score of two or more is considered 
a positive screen and requires further assessment. 
CRAFFT 
C	 Have you ever ridden in a CAR driven by someone 
(including yourself ) who was high or had been using 
alcohol or drugs? 
R	 Do you ever use alcohol or drugs to RELAX, feel 
better about yourself, or fit in? 
A	 Do you ever use alcohol or drugs while you are by 
yourself, ALONE? 
F	 Do you ever FORGET things you did while using 
alcohol or drugs? 
F	 Do your family or FRIENDS ever tell you that you 
should cut down on your drinking or drug use? 
T	 Have you ever gotten into TROUBLE while you were 
using alcohol or drugs? 
Scoring: Each question on the CRAFFT is given a score 
of one point and a cut point of two provides 
moderate sensitivity and excellent specificity for 
identifying alcohol use disorders among adolescents. 
It is recommended that any positive answer on this 
measure be followed by further assessment of pattern 
of use to increase sensitivity and to guide decisions 
about the need for intervention. 
AUDIT - C 
The three questions on the AUDIT-C screener, taken from the
original Alcohol Use Disorders Identification Test (AUDIT) 
assessment tool, are: 
(1) During the last 12 months, about how often did you drink 
ANY alcoholic beverage? 
(2) Counting all types of alcohol combined, how many drinks 
did you USUALLY have on days when you drank during 
the last 12 months?
(3) During the last 12 months, about how often did you drink 
FIVE OR MORE drinks in a single day? 
Scoring: Scores range from zero to four on each question. 
The AUDIT-C demonstrates good sensitivity and 
specificity at a cut point of three or greater for 
identifying risk drinking among nonpregnant and 
pregnant women, and performs well among different 
racial and ethnic groups. 
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APPENDIX C: Efforts To Support Alcohol 
Screening and Brief Intervention 
In 2004, the U.S. Preventive Services Task Force, coordinated 
by the Agency for Healthcare Research and Quality, released 
recommendations on screening and behavioral counseling 
interventions for alcohol misuse. Based on a systematic review 
of the literature, the task force recommended that health 
providers screen all adolescent and adult patients in primary 
care settings for alcohol misuse and provide counseling 
interventions for those identified as risky or harmful drinkers.
Referral to more intensive treatment options was recommended
for those clients with alcohol dependence or abuse [6]. 
The Purchaser’s Guide to Clinical Preventive Services: Moving
Science into Coverage was published in 2006 [155]. This 
guide, developed in a collaborative effort between CDC and 
the National Business Group on Health, translates clinical 
guidelines and medical evidence to assist large employers with
the information to help them select, define, and implement 
preventive medical benefits in over 40 different health areas. 
This guide not only recognizes the importance of alcohol 
misuse screening among the adult population, but also 
recommends alcohol misuse screening for pregnant women and
women planning a pregnancy. 
In January 2007, new billing codes allow the U.S. Centers 
for Medicare and Medicaid Services (CMS) to reimburse 
for alcohol and drug screening services, including codes for 
both alcohol screening and brief intervention and counseling
[156]. More and more medical boards, businesses, and other
organizations are recognizing the effectiveness of these strategies 
in reducing alcohol and drug misuse in the United States. 
The Substance Abuse and Mental Health Services 
Administration currently funds 17 state-based screening, brief
intervention, referral, and treatment programs. CDC and the 
NIAAA have also recognized the effectiveness and importance 
of screening and brief intervention through the development of
provider tool kits focused on screening and brief intervention 
guidelines for women of childbearing age specifically, and the 
adult population in general. 
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